Talphera Inc. (TLPH)

[dantheman1973]

Clearly it did.

[dantheman1973]

How will acrx do on May 10 report?

[wannabemillionaire]

https://www.fool.com/investing/2021/03/09/2-penny-stocks-that-could-make-you-filthy-rich/

[ClayTrader]

* * $ACRX Video Chart 01-25-2021 * *

Link to Video - click here to watch the technical chart video

[PRED2020]

The offering was for 1.7625 why would a big house buy 27 million shares atr 1.7625 when they can buy em for a $1? Don't make sense they don't do business like that to lose millions. This isn't going below 1.76!

[PRED2020]

Is there not one stock you don't spam? youtube ihub, yahoo, stocktwits, robinhood. No trading site left untouched.

[Gonzal]

New here. I imagine being headquartered in Palo Alto and that cost of living and operating cost plays a factor in their decision making process. Need a shareholder wealth maximizer focus. But they do have big tech marketing friends I’m sure.

DD Positives!!! Sufentanil oral tab has an excellent market in global military medicine and post-op care. Once Anesthesia providers make it the standard of care it will fly faster. And the public message of less opioid use is gold!

I see combat medics / Med-evac teams carrying doses. The REMs program would not matter as DoD would receive a waiver from FDA. Just like they did with Actiq (Fentanyl) lollipops!

[island man]

good to daytrade

[dantheman1973]

Sucks. Good news for potential 8 to 9 dollar price target, deal and then down 1 dollar. Worried its heading back down to 1 dollar.

[cervelo]

typical management move to line their own pockets and dump on those investors that provided the funds to get where they are/were

[erdos47]

They announced a bunch of new shares for sale. every time a company does this it tanks the stock right after good news comes out. It sets back the credibility of the company and makes it harder for a run up in the future. management really dumped on shareholders

[cervelo]

makes no sense that we were up almost a dollar and ended up down.
something stinks here

[island man]

Hey Alyssa
looking good today

[Dspetry]

Hey Clay...
Why is it that EVERYTIME you do a chart analysis, the stock goes down the next day?

Serious question - Do you short these?

[Alyssa]

[island man]

Hoping we could get and stay over 2 bucks today

[Alyssa]

I think you're right about that! The time for beating this stock to death should be over and done with.

[island man]

Nice finish to the day 2021 could be the year this gets some grip

[Dspetry]

There goes the neighborhood.

Let us know when the crew is done manipulating those one.

[ClayTrader]

* * $ACRX Video Chart 01-12-2021 * *

Link to Video - click here to watch the technical chart video

[Alyssa]

Yes, finally! Patience will pay off.

[island man]

Finally a move in the right direction

[Dspetry]

In line with his bullish stance, Folkes rates ACRX a Buy, and his $9 price target implies room for a stunning 552% upside potential in the next 12 months.

https://www.tipranks.com/news/article/these-2-penny-stocks-could-surge-over-300-say-analysts/

[Dspetry]

Heard this one has promise?

[cervelo]

i see zero resistance. 0 would be resistance

[dantheman1973]

2.10 seems like a strong resistance.

[OTCPIMP]

get ready for liftoff

[OTCPIMP]

You may want to be buying as much as you get this week

[whytestocks]

Breaking News: $ACRX 4 Penny Stocks To Watch This Week As Biotech Sector Pushes Higher

Biotech Stocks To Watch Heading Into The Week Are biotech stocks part of your penny stock strategy this week? If not, you may want to take a look at the recent sector trends in healthcare and biotechnology. While mainstream traders are yearning for things like tech and ...

Find out more ACRX - 4 Penny Stocks To Watch This Week As Biotech Sector Pushes Higher

[cervelo]

company needs to push harder that a 3 million dollar contract to get the stock up. guess i should look at this as a positive since i am only down 55% now

[whytestocks]

Just In: $ACRX AcelRx Awarded U.S. Army Contract for DSUVIA®

AcelRx Awarded U.S. Army Contract for DSUVIA® DSUVIA contract award for up to $3.6 million from the U.S. Army Contract award in addition to expected purchases for medical assemblages and sets, kits and outfits PR Newswire REDWOOD CITY, Calif., Sept. 22, 2020 ...

In case you are interested ACRX - AcelRx Awarded U.S. Army Contract for DSUVIA®

[ClayTrader]

* * $ACRX Video Chart 09-21-2020 * *

Link to Video - click here to watch the technical chart video

[whytestocks]

BREAKING NEWS: $ACRX 4 Penny Stocks To Watch That You Might Have Overlooked This Month

Did You Miss These Penny Stocks? There’s no doubt that there are plenty of penny stocks to watch this month. One of the biggest problems is choosing whether to go with the parabolic, one-day movers or search for swing trades. No matter which you choose, hopefully, you’...

Read the whole news ACRX - 4 Penny Stocks To Watch That You Might Have Overlooked This Month

[dreadlockcowboy]

Have we found stronger hands??

[whytestocks]

NEWS: $ACRX 4 Robinhood Penny Stocks To Watch This Week

Are These The Best Robinhood Penny Stocks To Buy Right Now? Whether you’re looking for penny stocks on Robinhood, TD Ameritrade, Webull, ETrade, or even Interactive Brokers, there’s no shortage of options to choose from. Why focus on mobile penny stock trading platforms like R...

Find out more ACRX - 4 Robinhood Penny Stocks To Watch This Week

[whytestocks]

NEWS: $ACRX AcelRx Announces DSUVIA® Added to the U.S. Department of Defense's Joint Deployment Formulary

REDWOOD CITY, Calif. , Sept. 14, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the ...

Find out more ACRX - AcelRx Announces DSUVIA® Added to the U.S. Department of Defense's Joint Deployment Formulary

[T695]

Buy buy buy

[whytestocks]

News: $ACRX AcelRx Pharmaceuticals Announces Publication of Clinical Data on Reduced Opioid Use and Reduced Time in the Postanesthesia Care Unit (PACU) Following Preoperative Administration of DSUVIA®

REDWOOD CITY, Calif. , Aug. 19, 2020 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the publication of a stud...

Read the whole news ACRX - AcelRx Pharmaceuticals Announces Publication of Clinical Data on Reduced Opioid Use and Reduced Time in the Postanesthesia Care Unit (PACU) Following Preoperative Administration of DSUVIA®

[T695]

Come on run

[T695]

Can we get a run today

[Trons]

Calling bottom here

[T695]

Buy buy buy

[T695]

Lotto calls

[dsscam]

Credit Suisse lowers price target to 69 cents. What a piece of garbage company and worst mgmt team in history of business.

[crawford2012]

I know they were talking about a 30 million contract, hope to hear about that in the near future.

[erdos47]

another site mentioned Scott Gotleib former head of FDA supporting desuvia as a safe alternative to other pain meds - not subject to abuse. Remember when he was the one who delayed approval for a year - setting the company back and leaving it here at this pps?

[dantheman1973]

Can only hope this is the start of many contracts Nd stock can get back up to atleast 5 dollars!

[crawford2012]

Breaking News - AcelRx Wins ~$3.5M US Army Medical Research Acquisition Contract For Dsuvia
5:33pm ET 7/16/2020 Benzinga

The United Stated Army Medical Research Acquisition Activity (USAMRAA), in support of the U.S. Army Medical Materiel Development Activity (USAMMDA), intends to negotiate solely (as prescribed in FAR 13.106(b)(1)(i)) with AcelRx Pharmaceuticals, Inc., 351 Galveston Drive, Redwood City, CA, 94063-4736, as the only responsible source that can provide one (1) commercial lot of 3,200 boxes of U.S. Food and Drug Administration (FDA) approved Sufentanil NanoTab brand name Dsuvia (New Drug Application (NDA)) # 209128 letter dated 12 December 2016. Dsuvia is for the management of acute pain in adults in medically supervised healthcare settings, such as hospitals, surgical centers, and emergency departments. Dsuvia is supplied in a 30 microgram tablet in a single-dose, prefilled applicator for administration by a healthcare professional, and it will not be available in retail pharmacies or for outpatient use. This acquisition is being conducted under FAR Part 12 Acquisition of Commercial Items. Provisions and clauses in effect through Federal Acquisition Circular (FAC) 2020-04, dated 15 January 2020, are incorporated.

USAMMDA, located in Fort Detrick, MD, is a subordinate activity under U.S. Army Medical Research and Development Command (USAMRDC) supporting the Command as the primary advanced development medical research, development, and acquisition organization within DOD and is responsible for meeting medical developmental requirements from both the Army and other military services. The USAMMDA is the Department of Defense's (DOD) medical product development activity for products designed to protect and preserve the lives of Warfighters. The USAMMDA develops new drugs, vaccines, devices, and medical support equipment that enhance readiness, ensures the provision of the highest quality medical care to the DOD, and maximizes survival of medical casualties on the battlefield. USAMMDA project managers guide the development of medical products for the U.S. Army Medical Department, other U.S. Services, the Joint Staff, the Defense Health Agency, and U.S. Special Forces community. The process takes promising technology from DOD, industry, and academia to U.S. Forces, from the testing required for FDA approval or licensing, to fielding and sustainment of the finished product.

USAMMDA’s, Warfighter Protection and Acute Care (WPAC) Project Management Office intends to procure firm-fixed-price contract for FDA approved brand name Dsuvia to be used to conduct a comparative clinical trial to aid clinical practice guideline development. USAMMDA has a requirement for one commercial lot of 3,200 boxes of FDA approved brand name Dsuvia, with a base and three (3) optional Contract Line Item Numbers (CLINs) to procure up to 3,000 boxes per CLIN of FDA brand name Dsuvia. The goal of the clinical trial is gain information regarding acceptability of Dsuvia compared to Oral Transmucosal Fentanyl Citrate (OTFC) in an Emergency Room (ER) setting in patients with moderate to severe pain requiring an opioid. The clinical trial contains several secondary endpoints including healthcare provider feedback. Based on the above information, the only technically acceptable product is provided by AcelRx Pharmaceuticals, Inc. The maximum estimated dollar amount for the duration of the contract is $3,525,800.00.

The intended procurement will be classified under North American Industry Classification System (NAICS) 325412 Pharmaceutical Preparation Manufacturing with a Small Business Size Standard of 1250 employees. This notice of intent is not a request for competitive proposals and no solicitation document will be posted for this requirement. However, parties interested in responding to this notice shall submit technical data, including cost, sufficient to determine capability in providing the same product. All capability statements received by closing of this notification of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.

[Pandemonium75]

Who cares what this board says or doesn't say? LOL -it hasn't been a place of information on this stock for a long time. You place too much emphasis on Ihub if you are disappointed in a forum not reacting to a stock.

[dsscam]

This is the most pathetic message board of all time. MLNT goes private, screws their shareholders and now screwing ACRX shareholders and nobody comments